Why the study?
Sustained fetal tachycardia can lead to serious complications such as cardiovascular failure, nonimmune hydrops, and fetal death, and its management depends on multiple factors.
Fetal supraventricular tachycardia can be successfully managed with multidisciplinary care and tailored antiarrhythmic therapy, leading to favorable neonatal outcomes.
Case series illustrates fetal SVT management approaches; leaves open optimal protocols for prospective validation.
Fetal tachycardia complicates 1-2% of pregnancies, and a large percentage of these arrhythmias are supraventricular. Sustained fetal tachycardia can have serious complications for the fetus, including cardiovascular failure, nonimmune fetal hydrops, and fetal death. Management of fetal tachycardia depends on multiple factors. Here we present three different cases of fetal supraventricular tachycardia (SVT) and their management at a single institution.
No takes yet. Share an insight, caveat, or question.
Rahel et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: